Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy
FRONTIERS IN IMMUNOLOGY（2022）
关键词
esophageal squamous cell carcinoma (ESCC), camrelizumab, immune checkpoint inhibitor (ICI), neoadjuvant chemotherapy, efficacy, surgery
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要